Information about Livtencity (Maribavir)
Livtencity (maribavir) is an antiviral medication used primarily to treat cytomegalovirus (CMV) infections, particularly in immunocompromised patients, such as those undergoing organ transplantation or with HIV/AIDS.
Product Highlights
- Maribavir works by inhibiting the replication of CMV through a novel mechanism that targets viral proteins.
- Indicated for the treatment of adults with CMV infections, especially in those who are at high risk, such as transplant recipients.
Key Ingredient
Key Benefits
- Specifically designed to combat CMV, providing an alternative to traditional antiviral therapies.
- Convenient oral dosing allows for easier administration compared to intravenous therapies.
- Generally has a favorable safety profile compared to some other antiviral treatments.
Direction of Use
- The recommended dose is typically 400 mg taken orally twice daily.
- Can be taken with or without food.
Safety Concerns
- May include fatigue, diarrhea, nausea, and headache.
- Potential for liver enzyme elevation and other rare adverse effects; regular monitoring may be required.
Avoid Livtencity (Maribavir) If
- You are allergic to maribavir or any of its components.
- You have severe liver impairment, as this may affect drug metabolism.
- Consult a healthcare provider if pregnant or breastfeeding, as safety in these populations has not been fully established.
- Avoid if taking medications that may interact adversely, especially those affecting liver enzymes.
